Pay in 4 interest-free payments of $13.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Inhibition of intracellular Ca2+ release by a Rho-kinase inhibitor for the treatment of ischemic damage in primary cultured rat hippocampal neurons
44)45)54-35(30)55-64(4
ATM expression predicts Veliparib and Irinotecan sensitivity in gastric cancer by mediating P53 independent regulation of cell cycle and apoptosis
CAS Number: 215303-72-3
Delanzomib (CEP-18770) - CAS# 847499-27-8 size:2mg solid Inhibition of intracellular Ca2+ releaseDelanzomib (CEP 18770), CAS No. 847499 27 8, also known as CEP 18770, is An orally bioavailable synthetic P2 threonine boronic acid inhibitor of the chymotrypsin like activity of the proteasome, with potential antineoplastic activity. Proteasome inhibitor CEP 18770 represses the proteasomal degradation of a variety of proteins, including inhibitory kappaBalpha (IkappaBalpha), resulting in the cytoplasmic sequestration of the transcription factor NF
US$ 14.00
US$ 12.95
US$ 47.95
US$ 19.80
US$ 42.00